Question 1

Does BNP Paribas Financial Markets own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 230,954 shares of AXSM (Axsome Therapeutics), worth $56.5M.

Question 2

How many shares of AXSM does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 230,954 shares of AXSM (Axsome Therapeutics).

Question 3

What is BNP Paribas Financial Markets' AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' AXSM position is worth $56.5M.

Question 4

Is BNP Paribas Financial Markets buying or selling AXSM?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets increased its AXSM position by 42,808 shares (+22.8%).

Question 5

When did BNP Paribas Financial Markets first buy AXSM?

Accepted Answer

BNP Paribas Financial Markets already held AXSM in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	230,954	+22.8%	$56.5M	0.0%	$244.77	36
2026-Q1	Decreased	188,146	-38.2%	$31.8M	0.0%	$169.02	0
2025-Q4	Increased	304,388	+60.1%	$55.6M	0.0%	$182.64	42
2025-Q3	Increased	190,106	+2.0%	$23.1M	0.0%	$121.45	29
2025-Q2	Increased	186,437	+2.1%	$19.5M	0.0%	$104.39	29
2025-Q1	Decreased	182,632	-1.6%	$21.3M	0.0%	$116.63	0
2024-Q4	Increased	185,661	+1251.9%	$15.7M	0.0%	$84.61	45
2024-Q3	Increased	13,733	+71.8%	$1.2M	0.0%	$89.87	38